patient experience

Kyle Garcia
Kyle Garcia
Kyle Garcia is fighting his brain tumor to be healthy enough for playtime with his four- and two-year-old sons, Max and Oliver.
Kyle Garcia
“Cancer is not stopping me from cheering for my daughter”
“Cancer is not stopping me from cheering for my daughter”
Cancer hasn’t stopped Shelly Zaugg from traveling the US to see her daughter play softball. She has a team of support—on and off the diamond.
“Cancer is not stopping me from cheering for my daughter”
Marino DiRienzo
Marino DiRienzo
What does time well spent mean? For Marino DiRienzo, it’s simply another day spent with family.
Marino DiRienzo
Doc Sinclair
Doc Sinclair
Family, music, rocks, fish — Doc Sinclair is a man of many passions. As he faces brain cancer, he strives to maintain an active, full life.
Doc Sinclair
Janice Armbrust
Janice Armbrust
Decades of hiking and rock climbing taught Janice Armbrust how to handle the greatest uphill battle of her life: one day — one step — at a time.
Janice Armbrust
Mike Hugo
Mike Hugo
Mike Hugo has packed a lot of life in his years, and he wants to teach his daughters to live with the same vigor and resolve.
Mike Hugo
Linda Long
Linda Long
Linda Long always saw the road ahead as she pursued her dream, making history in the Philadelphia Fire Department. Then she was diagnosed with glioblastoma.
Linda Long
Jovan Knutson
Jovan Knutson
A glioblastoma diagnosis led Jovan Knutson to reevaluate what is most important to her. She has found joy in the moment, and with it, a renewed sense of purpose and resilience.
Jovan Knutson

our culture

‘the courage of our patients inspired me to keep going’
‘the courage of our patients inspired me to keep going’
Read how Yasushi ‘Joe’ Ishikawa from Novocure Japan overcame the challenge of running a 136 mile ultramarathon in the Bolivian mountains.
‘the courage of our patients inspired me to keep going’
‘making our therapy accessible to patients motivates me’
‘making our therapy accessible to patients motivates me’
Our colleagues’ passion for patients often leads to remarkable career paths. Read how Jana Meyer zu Drewer’s drive to make a difference in cancer guided her, from providing technical therapy support to our patients in Germany, to educating doctors about our therapy.
‘making our therapy accessible to patients motivates me’
from hospitality to medtech
from hospitality to medtech
Because our mission of making a difference in cancer resonated deeply with her, Lea Pachur left her previous job as a hotel receptionist and joined us as a Management Assistant and Office Manager in our office in Munich.
from hospitality to medtech
unafraid to innovate
unafraid to innovate
Katia Felix is not afraid to share her ideas. Throughout her career, she has paved a way for herself often by bringing her ideas to the table.
unafraid to innovate
employee spotlight: Javier Beltran
employee spotlight: Javier Beltran
Javier Beltran, Device Support Specialist, prioritizes being there for patients. He finds much satisfaction in giving patients a sense of empowerment over their cancer treatment.
employee spotlight: Javier Beltran
working behind the scenes of our clinical trials
working behind the scenes of our clinical trials
With her colleagues, Alice Chen, Associate Director, Clinical Trial Management, has been managing our clinical trials from beginning to completion.
working behind the scenes of our clinical trials
‘we have the privilege to live our patient-forward mission’
‘we have the privilege to live our patient-forward mission’
Karin Gottwald’s passion for nursing was ignited at the age of nine. Today, she works for our company as a Senior Device Support Specialist with empathy and a smile.
‘we have the privilege to live our patient-forward mission’
enhancing awareness, scientific understanding of our therapy
enhancing awareness, scientific understanding of our therapy
Lamia Kalfane is determined to dedicate the remainder of her career to making the most significant difference possible in the lives of cancer patients.
enhancing awareness, scientific understanding of our therapy

features

Novocure joins New Hampshire Life Sciences
Novocure joins New Hampshire Life Sciences
We will work with industry partners to champion New Hampshire’s cutting-edge life sciences sector and improve patients’ lives.
Novocure joins New Hampshire Life Sciences
extra in the ordinary
extra in the ordinary
Share stories of finding purpose and joy in simple moments while living with GBM.
extra in the ordinary
you are not alone in facing a cancer diagnosis
you are not alone in facing a cancer diagnosis
Lean on patient advocacy groups for the support you need.
you are not alone in facing a cancer diagnosis
a Q&A with our founder
a Q&A with our founder
Novocure founder Professor Yoram Palti, recipient of the 2022 Israel Prize for excellence in entrepreneurship and technological innovation, reflects on his discovery of Tumor Treating Fields.
a Q&A with our founder
Novocure pledges $250K to Families First Health and Support Center
Novocure pledges $250K to Families First Health and Support Center
We committed the lead corporate gift to the capital campaign for a New Hampshire community health center’s new home.
Novocure pledges $250K to Families First Health and Support Center
lighting the world blue
lighting the world blue
Mesothelioma Awareness Day takes place annually in the U.S. on Sept. 26.
lighting the world blue
standing with the brain tumor community
standing with the brain tumor community
As a global oncology company focusing on improving survival in some of the most aggressive forms of cancer, Novocure proudly stands with the brain tumor community during May for Brain Tumor Awareness Month (BTAM).
standing with the brain tumor community
Ignace Vergote, Novocure Clinical Trial Investigator
Ignace Vergote, Novocure Clinical Trial Investigator
Professor Ignace Vergote has dedicated his 32-year career to investigating treatment options and striving to improve survival in gynecologic cancers. Among gynecologic cancers, ovarian cancer is the deadliest, representing the fifth most common cause of cancer death among women in the United States. Five-year survival in ovarian cancer has slowly increased from 34 percent in 1975 to 47 percent today.
Ignace Vergote, Novocure Clinical Trial Investigator